Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder

Baker G. B., Coutts R. T., Bornstein R. A., Dewhurst W. G., Douglass A. B., and MacDonald R. N. (1986) A rapid and sensitive gas chromatographic procedure for analysis of 3-methoxy-4-hydroxyphenylethylene glycol in urine.Res. Commun. Chem. Path. Pharmacol. 54, 141–144.

Baker G. B., Bornstein R. A., Rouget A. C, Ashton S. E., van Muyden J. C., and Coutts R. T. (1990) Phenylethylaminergic mechanisms in attention deficit disorder.Biol. Psychiatry 29, 15–22.

Baker G. B., Bornstein R. A., Douglass A. B., Carroll A., and King G. (1991) Urinary excretion of metabolites of norepinephrine in Tourette Syndrome.Mol. Chem. Neuropathol. 13, 225–232.

Bornstein R. A. and Baker G. B. (1990) Urinary amines in Tourette Syndrome patients with and without phenylethylamine abnormality.Psychiatry Res. 31, 279–286.

Bornstein R. A., Baker G. B., Carroll A., King G., and Ashton S. (1990) Phenylethylamine metabolism in Tourette Syndrome.J. Neuropsychiat. Clin. Neurosci. 2, 408–412.

Bowden C. L., Redmond D. E., Swann A., and Maas J. W. (1981) Pretreatment amine neurotransmitter system interrelationships in depression.Psychopharmacol. Bull. 17, 70–72.

Cardon P. V. and Guggenheim F. G. (1970) Effects of large variations in diet on free catecholamines and their metabolites in urine.J. Psychiat. Res. 7, 263–273.

Coutts R. T., Baker G. B., LeGatt D. F., McIntosh G. J., Hopkinson G., and Dewhurst W. G. (1981) Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection.Progr. Neuropsychopharmacol. 5, 565–568.

Davis B. A. (1989) Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.J. Chromatogr. 466, 89–218.

Elia J., Borcherding B. G., Potter W. Z., Mefford I. N., Rapoport J. L., and Keysor C. S. (1990) Stimulant drug treatment of hyperactivity: biochemical correlates.Clin. Pharmacol. Ther. 48, 57–66.

Greenspan K., Schildkraut J. J., Gordon E. K., Levy B., and Durell J. (1969) Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine and VMA excretion in hypomanic patients.Arch. Gen. Psychiat. 21, 710.

Khan U. A. and Dekirmenjian H. (1981) Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.Am. J. Psychiat. 138, 108–112.

Muscettola G., Potter W. Z., Pickar D., and Goodwin F. K. (1984) Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings.Arch. Gen. Psychiat. 41, 337–342.

Rapoport J. T., Mikkelsen E. J., Ebert M. H., Brown G. L., Weise V. T., and Kopin I. J. (1978) Urinary catecholamine and amphetamine excretion in hyperactive and normal boys.J. Nerv. Ment. Dis. 166, 731–737.

Shapiro A. K., Shapiro E. S., Young J. G., and Feinber T. E. (1988)Gilles de la Tourette Syndrome (2nd ed.), Raven, New York.

Sharpless N. S. (1977) Determination of 3-methoxy-4-hydroxyphenylglycol in urine and the effect of diet on its excretion.Res. Commun. Chem. Path. Pharmacol. 18, 257–273.

Shekim W. O., Dekirmenjian H., and Chapel J. L. (1977) Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.Am. J. Psychiat. 134, 1276–1279.

Shekim W. O., Dekirmenjian H., and Chapel J. L. (1979a) Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.Am. J. Psychiat. 136, 667–671.

Shekim W. O., Dekirmenjian H., Chapel J. L., Javaid J., and Davis J. M. (1979b) Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.J. Pediatrics 95, 389–394.

Shekim W. O., Javaid J., Dans J. M., and Bylund D. B. N. (1983) Urinary MHPG and HVA excretion in boys with attention-deficit hyperactivity disorder and hyperactivity treated with d-amphetamine.Biol. Psychiat. 18, 707–714.

Shen, Y. and Wang Y. (1984) Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three school children with minimal brain dysfunction syndrome.Biol. Psychiat. 19, 861–870.

Wender P., Epstein R. S., Kopin I. J., and Gordon E. K. (1971) Urinary monoamine metabolites in children with minimal brain dysfunction.Am. J. Psychiat. 127, 1411–1415.

Zametkin A. J. and Rapoport J. T. (1987) Neurobiology of attention-deficit hyperactivity disorder with hyperactivity: where have we come in 50 years?J. Am. Acad. Child Adol. Psychiat. 26, 676–686.

Zametkin A. J., Karoum F., Rapoport J. L., Brown G., and Wyatt R. J. (1984) Phenylethylamine excretion in attention deficit disorder.J. Am. Acad. Child Adol. Psychiat. 23, 310–314.

Zametkin A. J., Karoum F., Linnoila M., Rapoport J. L., Brown G. L., Chuang L.-W., and Wyatt R. J. (1985) Stimulants, urinary catecholamines, and indoleamines in hyperactivity: a comparison of methylphenidate and dextroamphetamine.Arch. Gen. Psychiat. 42, 251–255.